BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk BPC 157: Experimental Peptide Creates Risk for Athletes The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA moves toward easing restrictions on certain peptides BioPharma Dive Peptides Lack Reliable Safety Information, Watchdog Warns The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York